Page 30 - 1.HTAIn_Process_Manual

CHAPTER 3

STAKEHOLDER’S ENGAGEMENT POLICY

3. INTRODUCTION

The quality, usefulness and legitimacy of HTA can be improved by open and

consultative processes. The interested parties affected by a recommendation for a

health intervention are called the stakeholders. Stakeholders are individuals,

organizations or communities that are directly affected or, have a direct interest in the
process and/or outcomes of a health technology assessment. Stakeholders in the HTA

process could be:

 The User Department (e.g. RSBY or NPPA, NHM)

 Central Government and/or State Government Public health authorities

 Policy makers

 Healthcare organizations (e.g. Indian Medical Association)

 Insurance Providers

 Regulatory agencies

 Industrial associations (e.g. manufacturers, suppliers, wholesalers, distributors

and retailers)

 Patients (patient organization, disease specific society or organization)

 Academics or Methodological experts

 Researchers

 Social groups (NGOs, Advocacy groups, Ethical groups etc.)

Stakeholders are distinct from the common public as they are impacted by the the
process and/ or recommendations of an HTA. The impact can be on patient outcomes,

service provision, income, or out of pocket expenditure. Therefore, their participation

in HTA is both rational and likely to contribute to the quality and legitimacy of the

process and outcomes. Stakeholders may provide valuable inputs on different aspects

of HTA (epidemiology, grey literature, therapy, clinical efficacy and effectiveness, cost
and budget impact) at different stages of the HTA.

29 | P a g e